Kanadaptin rabbit pAb
ENT-A3022
Description
| REF | ENT-A3022 |
|---|---|
| Category | Antibody Polyclonal |
| Description | Kanadaptin rabbit pAb |
| Source | Rabbit |
| Applications | WB;IHC;IF;ELISA |
| Reactivity | Human;Mouse |
| Reactivity | Human;Mouse |
| Dilution | Western Blot: 1/500 – 1/2000. Immunohistochemistry: 1/100 – 1/300. Immunofluorescence: 1/200 – 1/1000. ELISA: 1/10000. Not yet tested in other applications. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human NADAP. AA range:421-470 |
| Storage Stability | -20°C/1 year |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1 mg/ml |
| Observed Band KD | 85kD |
| Human Gene ID | 22950 |
| Human Swiss Prot Nº | Q9BWU0 |
| Subcellular Location | Nucleus . Cytoplasm . Mainly nuclear. Small amounts are found in the cytoplasm. |
Other Name: SLC4A1AP; HLC3; Kanadaptin; Human lung cancer oncogene 3 protein; HLC-3; Kidney anion exchanger adapter protein; Solute carrier family 4 anion exchanger member 1 adapter protein
Background: caution:PubMed:15764369 initially suggested a role in targeting SLC4A1 (kidney anion exchanger 1) to the plasma membrane; it does not seem to do so as it does not interact with SLC4A1 and has no effect on SLC4A1 trafficking.,online information:Band 3 entry,PTM:Phosphorylated upon DNA damage, probably by ATM or ATR.,similarity:Contains 1 FHA domain.,subcellular location:Mainly nuclear. Small amounts are found in the cytoplasm.,tissue specificity:Ubiquitously expressed.,